| Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | 10/04 16:01 | businesswire.com |
| Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome | 09/26 08:30 | businesswire.com |
| Longboard Stock Soars on FDA Designations for Epilepsy Drug | 09/20 14:36 | zacks.com |
| Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024 | 08/26 09:00 | businesswire.com |
| Longboard Pharmaceuticals, Inc. (LBPH) Q2 2024 Earnings Call Transcript | 08/04 13:39 | seekingalpha.com |
| Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates | 08/01 16:01 | businesswire.com |
| Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1 | 07/29 09:15 | businesswire.com |
| Longboard Pharmaceuticals (LBPH) Is a Great Choice for 'Trend' Investors, Here's Why | 07/25 09:50 | zacks.com |
| 3 Russell 2000 Growth Stocks That Could Be Worth the Risk | 07/23 07:00 | fool.com |
| Wall Street Analysts Think Longboard Pharmaceuticals (LBPH) Could Surge 43.7%: Read This Before Placing a Bet | 07/09 10:56 | zacks.com |